Infections with gastrointestinal nematode parasites have a major impact on human health and livestock production. Multi-drug resistant parasites are now present in most parts of the world and alternative control measures are urgently needed. This project is part of a new initiative by a major Animal Health company to develop vaccines against gastrointestinal parasites of sheep and cattle. The aim of this project is to develop a prototype nematode vaccine against the most pathogenic parasite of sheep. This will be a major step in the development of commercial parasite vaccines which will be of benefit to both veterinary and human medicine.
|Effective start/end date||8/11/06 → 8/11/11|
- Australian Research Council (ARC): A$965,000.00
- Australian Research Council (ARC): A$115,000.00
- Pfizer (Australia) (trading as Pfizer Australia Pty Limited): A$540,000.00